Technology | June 10, 2011

Philips Releases Economical Time-of-Flight PET/CT system

June 10, 2011 — This year at the SNM 2011 Annual Meeting, TruFlight Select, the first economical positron emission tomography (PET)/computed tomography (CT) system equipped with time-of-flight (TOF) technology, was debuted. Although the TruFlight Select PET/CT, made by Philips Healthcare, is designed to serve the needs of facilities with budget constraints, the system is equipped with Philips’ premium TOF technology, Astonish TF. Astonish TF is the same TOF technology driving Philips’ new high-end Ingenuity TF PET/CT and PET/MR systems, introduced at RSNA 2010. Astonish TF is now being standardized across the Philips PET portfolio, and Philips is offering our current TOF customers a performance upgrade to the latest version of Astonish TF.

TOF technology for positron emission tomography (PET) scanners is designed to enhance image quality by reducing image artifacts and providing higher sensitivity. The resulting images help clinicians better detect and locate lesions to increase diagnostic confidence and preserve healthy tissue during treatment. According to a recent study, TOF scans can help to improve lung and liver lesion detectability. In the study the improvement was more pronounced in heavy patients.

Compared to non-TOF systems, Astonish TF allows for up to 30 percent improved contrast resolution while maintaining quantitative accuracy. With 495 picosecond timing resolution on all new systems, Philips provides the fastest timing resolution of all currently available PET systems with TOF. Philips now offers TOF technology for virtually all budgets and clinical needs.

All Philips TOF PET/CT systems that have been purchased since 2006 can be upgraded to the latest version of Astonish TF for improved performance.

Prof. Wolfgang Weber of the nuclear medicine department at University Clinic, Freiburg is one of the first clinicians worldwide to upgrade to latest version of Astonish TF.

“The combination of advanced TOF technology with a newer PET/CT system has contributed to significant improvements in image quality, which helps us see small lesions in lymph nodes of overweight patients that may have been overlooked on non-TOF systems,” said Weber.

For more information: www.philips.com

Related Content

Rupa Sanghani, M.D., FASNC, director of Rush's nuclear cardiology and stress laboratory, explaining to ASNC 2019 attendees how Rush implemented its program during a tour of its PET-CT suite.

Rupa Sanghani, M.D., FASNC, director of Rush's nuclear cardiology and stress laboratory, explaining to ASNC 2019 attendees how Rush implemented its program during a tour of its PET-CT suite.
 

Feature | PET-CT | February 19, 2020 | Dave Fornell, Editor
As hospital imaging departments look to replace aging nuclear scanners with updated technology, many are asking if...
Siemens Healthineers Announces First U.S. Install of Biograph Vision PET/CT
News | PET-CT | March 06, 2019
Siemens Healthineers’ new Biograph Vision positron emission tomography/computed tomography (PET/CT) system has been...
Bruker Introduces New High-Performance Preclinical PET/CT Si78 System
Technology | PET-CT | September 26, 2018
September 26, 2018 — Bruker recently announced the introduction of the new preclinical...
FDA Clears New Imaging Functionalities for Biograph mCT PET/CT Systems
Technology | PET-CT | June 21, 2018
Siemens Healthineers will announce U.S. Food and Drug Administration (FDA) clearance of four new system features for...
Nuclear myocardial perfusion scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers. The image shows good clarity with delineation of the left ventricular edge and papillary muscles without cardiac gating.

Nuclear myocardial perfusion scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers. The image shows good clarity with delineation of the left ventricular edge and papillary muscles without cardiac gating.

Technology | PET-CT | June 05, 2018
June 5, 2018 — The U.S.
New PET-CT Scan Improves Detection in Rare Cardiac Condition
News | PET-CT | July 25, 2017
Using a new imaging technique that can diagnose cardiac sarcoidosis much more accurately than traditional tests,...
PET/CT, calcium blockages, heart attack risk, Intermountain study, American Heart Association, AHA Scientific Sessions 2016
News | PET-CT | November 15, 2016
Many people who experience chest pain but don’t have a heart attack breathe a big sigh of relief when a stress test...
PET/CT, atherosclerotic plaque detection, Stanford University

Application of dual-modality optical and PET/CT activity-based probe in experimental carotid inflammation model. Coronal noninvasive PET/CT scans of (A) healthy and (B) diseased mice with and without ligated carotid arteries respectively. Inset images show optical ex vivo florescence imagining of (A) healthy and (B) diseased carotid arteries.  PET/CT and optical images courtesy of Xiaowei Ma, Toshinobu Saito and Nimali Withana.

News | PET-CT | November 01, 2016
Researchers at Stanford University have demonstrated for the first time the use of a dual optical and positron emission...
GE Healthcare, Discovery MI PET/CT system, FDA clearance, RSNA 2016
Technology | PET-CT | October 05, 2016
GE Healthcare recently announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Discovery MI digital...
Overlay Init